CoChat

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors.

Open access

The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index; 7 of the 30 sources its claims cite were checked for support.

Abstract

We found significant linkage to a locus that includes the XPNPEP2 candidate gene encoding membrane-bound APP. Mutation screening of this QTL identified a large coding deletion segregating in one pedigree and an upstream single-nucleotide polymorphism (C-2399A SNP) which regulates APP activity. We found significant association of this SNP to ACEi-induced AE.

Overview

CoChat Summary

TL;DR

A genomewide linkage and candidate-gene study found that plasma aminopeptidase P (APP) activity is partly heritable and links to the XPNPEP2 locus, where a C-2399A variant is associated with reduced APP activity and ACE inhibitor–induced angioedema. The authors conclude that this variant may contribute to susceptibility to a potentially fatal adverse drug reaction.

Key findings

  • Plasma APP activity was heritable: 37.5% ± 26.5% in cohort 1 (P = .0336) and 33.6% ± 25.1% in all eight pedigrees combined (P = .0452).
  • Variance-component linkage analysis found a maximum two-point LOD score of 3.75 at the XPNPEP2_CA marker near XPNPEP2 in combined cohorts 1 and 2.
  • Mutation screening identified a 175-bp coding deletion (g.2953-3127del) in XPNPEP2 in one pedigree, predicted to produce a truncated 38-amino-acid protein, and an upstream C-2399A SNP segregating in seven of eight pedigrees.
  • The C-2399A SNP significantly accounted for the linkage signal: excluding the deletion pedigree, the XPNPEP2_CA linkage LOD dropped from 3.24 to 0.54, and the SNP was a significant covariate (P < .0001; proportion of variance explained = 0.3149).
  • In a case-control sample of 20 AE-ACEi cases and 60 controls, the A allele frequency was 27.3% in cases versus 11.1% in controls, with association P = .0364 by Armitage trend test.

Methods

  • Eight white pedigrees (cohort 1: five pedigrees, 88 DNA samples; cohort 2: three pedigrees, 35 DNA samples; 123 participants total) were selected because one member per family had a history of ACEi-associated angioedema and/or anaphylactoid reaction. Plasma APP activity was measured as the quantitative trait.
  • A 10-cM genomewide microsatellite scan (397 markers) enriched with seven markers around APP candidate regions was performed in cohort 1, followed by variance-component QTL linkage analysis in SOLAR; cohort 2 was genotyped for 11 markers covering regions with LOD > 1 and the XPNPEPL locus.
  • Mutation detection used SSCP, sequencing, RFLP, and allele-specific PCR for XPNPEP2 and XPNPEPL; mRNA from lymphoblastoid cells was analyzed for the deletion’s splicing effect. The case-control association used 20 AE-ACEi cases and 60 controls matched by country of origin and gender.

Limitations

  • The paper states that clinical diagnosis was not used in linkage analysis because of lack of power; controls were not matched for age; medical histories were unknown for US controls; and the biological significance of the C-2399A SNP remains undetermined.
  • The paper also states that functional expression analysis was unsuccessful because XPNPEP2 is poorly expressed in human lymphoblastoid cells, and that further investigation of other linked loci is necessary.
  • Evident from the text: the case-control association is small (20 cases, 60 controls) and not replicated; controls from Belgium and Canada had no history of ACEi therapy, so not all controls were ACEi-exposed; and only 9 of 20 AE-ACEi cases carried the identified variants, with one-third of cases having normal or high APP activity, indicating that the variant explains only a fraction of AE-ACEi risk.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1086/496899

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Cohorts included in variance-component linkage analysis. One member of each kindred, depicted in black, developed AE and/ or AR associated with ACEi therapy. All available members were quantified for plasma APP activity, shown as numbers that represent units of arginine released per minute per milliliter of plasma. Genotypes of the C-2399A SNP upstream of XPNPEP2 are shown as C/C, C/A, or A/ A for females, and C or A for males. a, DNA samples from cohort 1 were included in a genomewide microsatellite scan, which was analyzed for linkage using a variance-component method (SOLAR program). b, Eleven genome-scanned markers were genotyped in cohort 2 to further evaluate linkage. A large deletion (DEL) in XPNPEP2 segregates in pedigree VI.
Figure 1 Cohorts included in variance-component linkage analysis. One member of each kindred, depicted in black, developed AE and/ or AR associated with ACEi therapy. All available members were quantified for plasma APP activity, shown as numbers that represent units of arginine released per minute per milliliter of plasma. Genotypes of the C-2399A SNP upstream of XPNPEP2 are shown as C/C, C/A, or A/ A for females, and C or A for males. a, DNA samples from cohort 1 were included in a genomewide microsatellite scan, which was analyzed for linkage using a variance-component method (SOLAR program). b, Eleven genome-scanned markers were genotyped in cohort 2 to further evaluate linkage. A large deletion (DEL) in XPNPEP2 segregates in pedigree VI.From the PDF
Figure 2 Results of the variance-component QTL analyses in the five pedigrees of cohort 1. All results were corrected empirically for a ⩽ 0.05. a, String diagram of autosomal multipoint results, LODs 1 1, are shown next to a LOD scale. b, Two-point linkage analysis results including chromosome X.
Figure 2 Results of the variance-component QTL analyses in the five pedigrees of cohort 1. All results were corrected empirically for a ⩽ 0.05. a, String diagram of autosomal multipoint results, LODs 1 1, are shown next to a LOD scale. b, Two-point linkage analysis results including chromosome X.From the PDF
Figure 3 Coding deletion in XPNPEP2 . a, The deleted genomic region of 175 bp consists of 16 bp of exon 2 ( in blue ), the 3 ′ donor splice site ( in green ) and intronic sequences. b, The deleted allele (DEL) is present in four members of this pedigree who have negligible or reduced (in one female heterozygote) plasma APP activity. The two men with normal alleles (wt) both have high APP measurements. c, The deletion results in an abnormally spliced mRNA transcript coding for a premature stop codon that is predicted to translate into a severely truncated protein of 38 amino acids. This short peptide would not be membrane-bound because it lacks a glycosylphosphatidylinsitol (GPI) anchor attached to the alanine (A) at position 650.
Figure 3 Coding deletion in XPNPEP2 . a, The deleted genomic region of 175 bp consists of 16 bp of exon 2 ( in blue ), the 3 ′ donor splice site ( in green ) and intronic sequences. b, The deleted allele (DEL) is present in four members of this pedigree who have negligible or reduced (in one female heterozygote) plasma APP activity. The two men with normal alleles (wt) both have high APP measurements. c, The deletion results in an abnormally spliced mRNA transcript coding for a premature stop codon that is predicted to translate into a severely truncated protein of 38 amino acids. This short peptide would not be membrane-bound because it lacks a glycosylphosphatidylinsitol (GPI) anchor attached to the alanine (A) at position 650.From the PDF

Verification

Claims the paper makes

5 Valid · 1 Not valid · 15 Not checked · 34 Own results and interpretations

22 more claims

Create a free account to see all 55 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 19
  • Probably not a substantial claim. 19
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 129

Metadata

Authors
Duan, Q. L., Nikpoor, B., Dubé, M.-P., Molinaro, G., Meijer, I. A., Dion, P., Rochefort, D., Saint-Onge, J., Flury, L., Brown, N. J., Gainer, J. V., Rouleau, J. L., Agostoni, A., Cugno, M., Simon, P., Clavel, P., Potier, J., Wehbe, B., Benarbia, S., Marc-Aurèle, J., Chanard, J., Foroud, T., Adam, A., & Rouleau, G. A.
Affiliations
  • Hôpital Notre-Dame (CA)
  • Montreal Heart Institute (CA)
  • Université de Montréal (CA)
  • Vanderbilt University (US)
  • University of Milan (IT)
  • Centre Hospitalier de Saint-Brieuc (FR)
  • Centre Hospitalier Universitaire de Reims (FR)
  • Centre Hospitalier de Cornouaille (FR)
  • Hôpital de Saint-Jérôme (CA)
  • Indiana University Indianapolis (US)
Corresponding author
Rouleau, Guy A.
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2005-10
Volume
77
Issue
4
Pages
617-626
ISSN
0002-9297 (ISSN-L)
OpenAlex
W2141319262
Cited by
126
References
43
Citations by year
2026: 1 · 2025: 5 · 2024: 4 · 2023: 3 · 2021: 6 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 8 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 11
FWCI
3.72
Type
journal article
Language
en
Open access
Licence
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
Funders
  • McGill University
  • National Institutes of Health
  • Canadian Institutes of Health Research
  • National Heart, Lung, and Blood Institute (R01HL079184)
Topics
  • Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
angioedema, ACE inhibitors, aminopeptidase P, genetic susceptibility, single nucleotide polymorphisms, linkage analysis, quantitative trait loci, plasma enzyme activity, adverse drug reactions
MeSH terms
Aminopeptidases, Angioedema, Angiotensin-Converting Enzyme Inhibitors, Female, Humans, Genetic Linkage, Male, Mutation, Pedigree, Cohort Studies, Quantitative Trait Loci

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.